Menu Search
Equities

Koninklijke Philips NV

  • Add to watchlist
  • Add to portfolio
  • Add an alert
PHG:NYQ

Koninklijke Philips NV

Actions
Health CareMedical Equipment and Services
  • Price (USD)24.03
  • Today's Change-0.63 / -2.55%
  • Shares traded557.63k
  • 1 Year change-10.07%
  • Beta0.7341
Data delayed at least 15 minutes, as of Jul 11 2025 21:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Consensus recommendation

  • 18-Jul-24
  • 17-Apr-25
  • 15-May-25
  • 19-Jun-25
  • 10-Jul-25
Select bar for recommendation details.
Recommendations10-Jul-25
Buy1
Outperform0
Hold1
Sell0
Strong Sell0

Share price forecast in EUR

The 2 analysts offering 12 month price targets for Koninklijke Philips NV (ADR) have a median target of 28.08, with a high estimate of 30.23 and a low estimate of 25.94. The median estimate represents a 16.85% increase from the last price of 24.03.
High25.8%30.23
Med16.9%28.08
Low7.9%25.94

Dividends in EUR

Historical dividend information is not available for Koninklijke Philips NV.
Div growth (TTM)--
More ▼

Earnings history & estimates in EUR

On May 06, 2025, Koninklijke Philips NV (ADR) reported 1st quarter 2025 earnings of 0.25 per share. This result exceeded the 0.21 consensus of the 2 analysts covering the company and under-performed last year's 1st quarter results by 3.85%.
The next earnings announcement is expected on Jul 28, 2025.
Average growth rate+7.61%
Koninklijke Philips NV (ADR) reported annual 2024 earnings of 1.39 per share on Feb 19, 2025.
Average growth rate-2.45%
More ▼

Revenue history & estimates in EUR

Koninklijke Philips NV (ADR) had 1st quarter 2025 revenues of 4.10bn. This bettered the 3.95bn consensus of the 3 analysts covering the company. This was 0.99% below the prior year's 1st quarter results.
Average growth rate+0.60%
Koninklijke Philips NV (ADR) had revenues for the full year 2024 of 18.02bn. This was 0.81% below the prior year's results.
Average growth rate-0.28%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.